These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3657597)

  • 1. Gross cystic disease of the breast.
    Greenblatt RB; Mahesh VB; Sullivan D
    Maturitas; 1987 Aug; 9(2):171-81. PubMed ID: 3657597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture, and management.
    Vorherr H
    Am J Obstet Gynecol; 1986 Jan; 154(1):161-79. PubMed ID: 3511705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrocystic disease of the breast.
    Greenblatt RB; Samaras C; Vasquez JM; Nezhat C
    Clin Obstet Gynecol; 1982 Jun; 25(2):365-71. PubMed ID: 7105513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrocystic breast disease: the significance of beta-human chorionic gonadotropin and other polypeptides in breast cyst fluid.
    Abney TO; Teran AZ; Mahesh VB; Mullins WB; Greenblatt RB
    Fertil Steril; 1988 Apr; 49(4):638-43. PubMed ID: 2450789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour necrosis factor-alpha and interleukin-1 and -6 in fibrocystic breast disease.
    Herruzo A; Castilla JA; Ramírez A; Marcos C; Menjón S
    Breast Cancer Res Treat; 1999 Mar; 54(2):159-64. PubMed ID: 10424406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interaction between beta-endorphin, steroids and peptide hormones in fibrocystic lesions of the female breast].
    Schurz B
    Wien Klin Wochenschr Suppl; 1991; 187():3-26. PubMed ID: 1648846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and endocrinology of benign breast disease.
    Wang DY; Fentiman IS
    Breast Cancer Res Treat; 1985; 6(1):5-36. PubMed ID: 3902125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cyst fluid concentrations of beta-endorphin, steroids and gonadotrophins in premenopausal women with gross cystic disease.
    Schurz B; Schön HJ; Wenzl R; Kubista E; Spona J; Huber J; Weindlmayr-Goettel M
    Maturitas; 1991 Jun; 13(2):123-8. PubMed ID: 1921735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is cystic disease related to breast cancer?
    Haagensen DE
    Am J Surg Pathol; 1991 Jul; 15(7):687-94. PubMed ID: 2058763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of hormones in breast cyst fluid.
    Bradlow HL; Schwartz MK; Fleisher M; Nisselbaum JS; Boyar R; O'Connor J; Fukushima DK
    J Clin Endocrinol Metab; 1979 Nov; 49(5):778-82. PubMed ID: 489717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatment.
    Borkowski A; L'hermite M; Dor P; Longeval E; Rozencweig M; Muquardt C; Van Cauter E
    J Endocrinol; 1977 May; 73(2):235-46. PubMed ID: 140915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids.
    Hackenberg R; Schulz KD
    J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):113-7. PubMed ID: 8603031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Some aspects of fibrocystic breast disease].
    Mizia-Stec K; Zych F
    Pol Merkur Lekarski; 1997 May; 2(11):303-6. PubMed ID: 9377675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CA 125, CA 15.3, CA 27.29, CEA, beta-hCG and alpha-fetoprotein levels in cyst fluid of breast macrocysts.
    Martínez L; Castilla JA; Blanco N; Perán F; Herruzo A
    Int J Gynaecol Obstet; 1995 Feb; 48(2):187-92. PubMed ID: 7540567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of cyst type to risk factors for breast cancer and the subsequent development of breast cancer in patients with breast cystic disease.
    Dixon JM; Lumsden AB; Miller WR
    Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1047-50. PubMed ID: 4065177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor in breast cyst fluid: relationship with intracystic cation and androgen conjugate content.
    Boccardo F; Valenti G; Zanardi S; Cerruti G; Fassio T; Bruzzi P; De Franchis V; Barreca A; Del Monte P; Minuto F
    Cancer Res; 1988 Oct; 48(20):5860-3. PubMed ID: 2971432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mastopathy and breast cancer: is there a typical hormone profile?].
    Völker W; Leipert KP; Gehrlings H; Stauch G; von zur Mühlen A; Schneider J
    Geburtshilfe Frauenheilkd; 1986 May; 46(5):284-9. PubMed ID: 3087811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammary tumors and serum hormones in the bitch treated with medroxyprogesterone acetate or progesterone for four years.
    Frank DW; Kirton KT; Murchison TE; Quinlan WJ; Coleman ME; Gilbertson TJ; Feenstra ES; Kimball FA
    Fertil Steril; 1979 Mar; 31(3):340-6. PubMed ID: 437169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of cyst type with risk factors for breast cancer and relapse rate in women with gross cystic disease of the breast.
    Naldoni C; Costantini M; Dogliotti L; Bruzzi P; Bucchi L; Buzzi G; Torta M; Angeli A
    Cancer Res; 1992 Apr; 52(7):1791-5. PubMed ID: 1551110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous hormone use and fibrocystic breast disease by histopathologic component.
    Berkowitz GS; Kelsey JL; LiVolsi VA; Merino MJ; Holford TR; Hildreth NG; Ort S; O'Connor TZ; White C
    Int J Cancer; 1984 Oct; 34(4):443-9. PubMed ID: 6490201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.